These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7498270)

  • 1. Platelet-activating factor-induced loss of vascular responsiveness to noradrenaline in pithed rats: involvement of nitric oxide.
    Shiga T; Yoshikawa D
    Eur J Pharmacol; 1995 Aug; 282(1-3):151-6. PubMed ID: 7498270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats.
    Gray GA; Schott C; Julou-Schaeffer G; Fleming I; Parratt JR; Stoclet JC
    Br J Pharmacol; 1991 May; 103(1):1218-24. PubMed ID: 1908734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat.
    Yoshikawa D; Shiga T; Saito S; Morita T; Imai T; Goto F
    Eur J Pharmacol; 1998 Jan; 342(2-3):241-5. PubMed ID: 9548392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.
    Fabi F; Calabrese R; Stati T; del Basso P
    Br J Pharmacol; 2001 Oct; 134(4):777-88. PubMed ID: 11606318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
    Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M
    Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide mediates platelet-activating factor stimulatory action on uterine prostaglandin production.
    Chaud MA; Franchi AM; Berón de Astrada M; Gimeno MF
    Prostaglandins Leukot Essent Fatty Acids; 1998 Jan; 58(1):55-9. PubMed ID: 9482166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK; Strandhoy JW; Handa SE
    Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.
    Noel AA; Fallek SR; Hobson RW; Durán WN
    J Vasc Surg; 1995 Dec; 22(6):661-9; discussion 669-70. PubMed ID: 8523600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
    Ramírez MM; Quardt SM; Kim D; Oshiro H; Minnicozzi M; Durán WN
    Microvasc Res; 1995 Sep; 50(2):223-34. PubMed ID: 8538502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.
    Filep JG; Földes-Filep E
    Br J Pharmacol; 1993 Dec; 110(4):1347-52. PubMed ID: 8306074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG; Thiemermann C
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production.
    Mariano F; Bussolati B; Migliori M; Russo S; Triolo G; Camussi G
    Shock; 2003 Apr; 19(4):339-44. PubMed ID: 12688545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interdependence of contractile responses of rat small mesenteric arteries on nitric oxide and cyclo-oxygenase and lipoxygenase products of arachidonic acid.
    Wu XC; Johns E; Michael J; Richards NT
    Br J Pharmacol; 1994 Jun; 112(2):360-8. PubMed ID: 7521254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
    Handa RK; Strandhoy JW
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1486-91. PubMed ID: 8667214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of nitric oxide-like activity by prostanoids in smooth muscle of the canine saphenous vein.
    Illiano S; Marsault R; Descombes JJ; Verbeuren T; Vanhoutte PM
    Br J Pharmacol; 1996 Jan; 117(2):360-4. PubMed ID: 8789391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension.
    Calver A; Collier J; Vallance P
    Cardiovasc Res; 1994 Nov; 28(11):1720-5. PubMed ID: 7531114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
    Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
    Artery; 1998; 23(1):1-9. PubMed ID: 10846613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of alpha-adrenoceptor-mediated pressor responses by NG-nitro-L-arginine methyl ester and vasopressin in endotoxin-treated pithed rats.
    Guc MO; Furman BL; Paratt JR
    Eur J Pharmacol; 1992 Nov; 224(1):63-9. PubMed ID: 1280596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nitric oxide synthesis inhibitor decreased prostaglandin production in rat mesenteric vasculature.
    Soma M; Izumi Y; Watanabe Y; Kanmatsuse K
    Prostaglandins; 1996 Mar; 51(3):225-32. PubMed ID: 8848552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor augments lipopolysaccharide-induced nitric oxide formation by rat Kupffer cells.
    Mustafa SB; Howard KM; Olson MS
    Hepatology; 1996 Jun; 23(6):1622-30. PubMed ID: 8675186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.